摘要
目的评价万拉法新治疗广泛性焦虑症的临床疗效和不良反应方法将76例符合CCMD-3诊断标准的广泛性焦虑症患者随机分为两组,分别应用万拉法新(38例)、氯硝安定(38例)进行对照治疗。疗程6周。采用焦虑自评量表(SAS)、Ham ilton焦虑量表(HAMA)和不良反应量表(TESS)评定疗效和不良反应。结果万拉法新与氯硝安定对广泛性焦虑症均有显著疗效,两组间疗效无显著性差异(P>0.05),万拉法新不良反应明显少于氯硝安定(P<0.01)。结论万拉法新治疗广泛性焦虑症安全有效,不良反应少。
Objective To evaluate the efficacy and side effects of venlafaxine in the treatment of generalized anxiety disorder. Methods 76 patients who met the criteria of CCMD - 3 for generalized anxiety disorder were randomly assigned into venlafaxine group and clonazepam group for treatment of 6 weeks. The efficacy and side effects of two groups were assessed by HAMD, SAS and TESS. Results Both drugs had marked efficacy in the treatment of generalized anxiety disorder. Conclusion Venlafaxine is a safe and efficient drug with fewer side effects for the treatment of generalized anxiety disorder.
出处
《四川精神卫生》
2006年第2期87-88,共2页
Sichuan Mental Health
